<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00745797</url>
  </required_header>
  <id_info>
    <org_study_id>CSLC0801</org_study_id>
    <nct_id>NCT00745797</nct_id>
  </id_info>
  <brief_title>Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy</brief_title>
  <acronym>PCI</acronym>
  <official_title>Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy：A Multi-center Randomized Phase ⅢTrial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yi-Long Wu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Society of Lung Cancer</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Patients with confirmed advanced NSCLC and any response to 3-6 cycles of chemotherapy,
           were randomized to receive PCI (30 Gy/10fr) or no PCI.

        2. The primary endpoint was the cumulative incidence of symptomatic brain metastases (BM) .

        3. The study was sized to detect a hazard ratio of 0.37 with 80% power and 2-sided 5%
           significance (60 events, 206 patients).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Prophylactic cranial irradiation (PCI) significantly reduces the risk of brain
           metastases (BM) and improves survival in patients with extensive disease small cell lung
           cancer after a response to chemotherapy .

        2. PCI has also demonstrated to reduce or delay the incidence of CNS failure in non small
           cell lung cancer patients after primary therapy.

        3. But its impact on overall and disease free survival is uncertain.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    this trial enroll extremely slow and No funding support
  </why_stopped>
  <start_date>April 2008</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The primary endpoint is the cumulative incidence of symptomatic brain metastases (BM) .</measure>
    <time_frame>2.5years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>1year survival,overall survival,incidence rate of radioactive brain injured</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Brain Metastases</condition>
  <arm_group>
    <arm_group_label>Prophylactic WBRT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Take the whole brain radiotherapy radiotherapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observer Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>The first 14 days after randomization and patient follow-up after 1 month to complete the FACT-L questionnaire and the MMSE scale.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radiotherapy</intervention_name>
    <description>blood transfusions, platelet transfusions, antibiotics, antipyretic analgesics and anesthetics</description>
    <arm_group_label>Prophylactic WBRT</arm_group_label>
    <other_name>Radiotherapy,Dehydration drugs, elevated white blood drugs,</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients were required to have histologically or cytologically documented NSCLC and no
             brain metastasis documented by magnetic resonance imaging (MRI)within 21 days after
             confirmed response (RR+SD) to chemotherapy

          2. No previous history of radiotherapy and surgery of brain

          3. Agree to radiotherapy

          4. age &gt; 18 and &lt;75 years

          5. ECOG performance status 1 or less

          6. Good renal and hepatic and haematological (absolute neutrophils count 15 x1O9/L and
             platelet count 90 x 109/L,HB&gt;=80g /DL) functions

          7. Have provided informed consent

        Exclusion Criteria:

          1. Seizure cannot be controled by the drugs

          2. Combined with other disease of the brain such as tumour or infarction

          3. Hypersensitivity to MR enhancer
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>WU YI LONG, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese Society of Lung Cancer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lung Cancer Research Institute &amp; Cancer Center of Guangdong Provincial People's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2008</study_first_submitted>
  <study_first_submitted_qc>September 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2008</study_first_posted>
  <last_update_submitted>March 2, 2017</last_update_submitted>
  <last_update_submitted_qc>March 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Society of Lung Cancer</investigator_affiliation>
    <investigator_full_name>Yi-Long Wu</investigator_full_name>
    <investigator_title>Professor, director</investigator_title>
  </responsible_party>
  <keyword>nonsmall cell lung cancer</keyword>
  <keyword>brain metastasis</keyword>
  <keyword>prophylactic cranial irradiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

